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Abstract
Introduction: Lyme neuroborreliosis is the most common bacterial central nervous system infection in the
temperate parts of the northern hemisphere. Even though human immunodeficiency virus (HIV) -1 infection is
common in Lyme borreliosis endemic areas, only five cases of co-infection have previously been published. Four of
these cases presented with typical Lyme neuroborreliosis symptoms such as meningoradiculitis and facial palsy,
while a fifth case had more severe symptoms of encephalomyelitis. All five were treated with intravenous
cephalosporins and clinical outcome was good for all but the fifth case
Case presentations: We present four patients with concomitant presence of HIV-1 infection and Lyme
neuroborreliosis diagnosed in Western Sweden. Patient 1 was a 60-year-old Caucasian man with radicular pain and
cognitive impairment. Patient 2 was a 39-year-old Caucasian man with headaches, leg weakness, and pontine
infarction. Patient 3 was a 62-year-old Caucasian man with headaches, tremor, vertigo, and normal-pressure
hydrocephalus. Patient 4 was a 50-year-old Caucasian man with radicular pain and peripheral facial palsy. Patients
one, two, and three all had subnormal levels of CD4 cells, indicating impaired immunity. All patients were treated
with oral doxycycline with good clinical outcome and normalization of CSF pleocytosis.
Conclusion: Given the low HIV-1 prevalence and medium incidence of Lyme neuroborreliosis in Western Sweden
where these four cases were diagnosed, co-infection with HIV-1 and Borrelia is probably more common than
previously thought. The three patients that were the most immunocompromised suffered from more severe and
rather atypical neurological symptoms than are usually described among patients with Lyme neuroborreliosis. It is
therefore important for doctors treating HIV patients to consider Lyme neuroborreliosis in a patient presenting with
atypical neurological symptoms. All four patients were treated with oral doxycycline with a good outcome, further
proving the efficacy of this regime.
Introduction
Lyme neuroborreliosis (LNB) is the most common bac-
terial central nervous system (CNS) infection in the
temperate parts of the northern hemisphere. European
LNB most often presents as a painful meningoradiculo-
neuritis, with or without facial palsy or other cranial
neuritis (Garin-Bujadoux-Bannwarth syndrome). More
uncommon symptoms include deficits of other cranial
nerves, myelitis and encephalitis [1].
To date, only five single cases of co-infection with
human immunodeficiency virus (HIV) -1 and LNB have
been published [2-6], all of whom were treated with
intravenous third-generation cephalosporins. In Sweden,
the recommended treatment for LNB has long been oral
doxycycline. We now present a case series of four
patients with HIV-1 infection that have been diagnosed
with LNB and successfully treated with oral doxycycline.
Case presentations
Patient 1
This 60-year-old Caucasian man had a medical history
including intermittent alcohol problems and depression,
for which he was treated with disulfiram and selective
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nosed with HIV 23 years earlier but did not start antire-
troviral therapy (ART) until 20 years after diagnosis
(lamivudine, tenofovir and ritonavir-boosted atazanavir).
Two years after commencing ART, he noticed a tick
bite but no erythema migrans. One year later, he was
admitted to hospital with confusion, psychomotor agita-
tion and hyponatremia (serum sodium 116 mmol/L). He
had completely stopped taking his HIV medication one
month earlier, after a period of deteriorating compli-
ance. The hyponatremia was thought to have been
caused by a combination of water intoxication, syn-
drome of inappropriate antidiuretic hormone secretion
and SSRI medication. It was corrected slowly and the
patient improved with regard to confusion and agitation,
but he showed remaining cognitive impairment. It was
also noted that he had trouble walking and suffered
from radicular pain in both legs. A computed tomogra-
phy (CT) scan of his brain was normal. A cerebrospinal
fluid (CSF) sample four weeks after admission showed
markedly elevated levels of albumin and mononuclear
cells (Table 1). High CSF and serum Borrelia antibody
titers were present and the Borrelia antibody index was
positive, indicating intrathecal antibody production.
Treatment was given with 200 mg of oral doxycycline
twice daily for 10 days. At the same time, ART was re-
started. Three weeks later, his pain and motor symp-
toms had improved. The number of CSF mononuclear
cells had decreased markedly (Figure 1). At follow-up
six months later, this patient’s symptoms had continued
to improve and the level of mononuclear cells in his
CSF was down to normal (data not shown).
Patient 2
This 39-year-old Caucasian man had primary HIV infec-
tion six years earlier. Two years after that, he fell ill with
Guillain-Barré syndrome, which was treated with intra-
venous gammaglobulin, and ART was started with sta-
vudine, lamivudine, saquinavir and nelfinavir given for
eight months. The Guillain-Barré symptoms resolved
[7]. He was admitted with slowly increasing headaches,
weakness in both legs and right hand tremor. On admis-
sion, he was still without ART and had a CD4 cell count
of 390 cells/μL. Two days before admission, this patient
had experienced a sudden onset of vertigo and hearing
loss in his right ear. A magnetic resonance imaging scan
showed a pontine infarction. Levels of albumin and
mononuclear cells in his CSF were markedly elevated
(Table 1). Borrelia-antibody titers were high in both his
serum and CSF, and the Borrelia antibody index was
positive. Treatment was given with 200 mg of oral doxy-
cycline twice daily for 19 days. His symptoms of head-
aches, weakness, tremor and vertigo started improving
within three days of starting treatment, but the hearing
loss remained. Repeated lumbar punctures showed
declining levels of CSF albumin (data not shown) and
mononuclear cells (Figure 1). At follow-up after six
months, he was still experiencing a complete hearing
loss in his right ear, but the other symptoms had sub-
sided. He still had no ART.
Table 1 Patients with HIV-1 and Lyme neuroborreliosis co-infection; baseline data, clinical and laboratory
characteristics
Patient
no.
Sex Age Years
since HIV
diagnosis
CD4 cell count
(cells/μL)
Viral load at
diagnosis of LNB
(copies/mL)
Symptoms of LNB CSF laboratory
data
Borrelia
diagnosis
History
of tick
bite
nadir at
diagnosis
of LNB
plasma CSF Mono-
nuclear
cells
(cells/μL)
Albumin
(mg/L)
1 m 60 24 190 190 65,907 1,100,000 radicular pain, cognitive
impairment
193 2790 CSF Bb-
antibodies +
positive Bb
antibody index
yes
2 m 39 6 280 390 83,400 448,000 hearing-loss, vertigo
(pontine infarction)
492 2860 CSF Bb-
antibodies +
positive Bb
antibody index
no
3 m 62 6 180 320 < 20 219 dysgeusia, vertigo,
incontinence, headache
(normal pressure
hydrocephalus)
93 2000 CSF Bb-
antibodies +
positive Bb
antibody index
no
4 m 50 5 180 450 nd nd headache, facial palsy 50 481 CSF Bb IgG
seroconversion
no
CSF: cerebrospinal fluid; m: male; nd: no data; Bb: Borrelia burgdorferi. Reference values: CD4 cells > 500 cells/μL, CSF mononuclear cells < 5 cells/μL, CSF
albumin < 420 mg/L.
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This 62-year-old Caucasian man was diagnosed with a
primary HIV infection seven years earlier. Viral load was
high and the CD4 cells were low at 180 cells/μL. ART
was started with lamivudine, zidovudine and ritonavir-
boosted lopinavir for one year and was re-started after
four years with efavirenz, abacavir and lamivudine. One
year later, the patient noted a change in the taste of cof-
fee but no other foodstuff. In the following months, he
experienced gradually increasing problems with vertigo
and unsteadiness. A few months later, he also noted
symptoms of tremor, urge incontinence and intermittent
headaches. A CT scan revealed normal-pressure hydroce-
phalus. Six months later, CSF sampling showed increased
levels of protein and mononuclear cells (Table 1). Culture
and polymerase chain reaction tests for opportunistic
infections were negative, but a cytological examination
pointed to a neurotrophic infection. Four months after
the first CSF analysis, a new analysis of CSF and serum
revealed high titers of CSF and serum Borrelia antibodies
and a positive antibody index, consistent with LNB.
Treatment was given with 200 mg of oral doxycycline
twice daily for 10 days. All the symptoms (including the
change of taste of coffee) started improving within five
days of treatment initiation. At follow-up two months
later, the symptoms had almost completely disappeared
and CSF levels of mononuclear cells and albumin had
normalized (Figure 1).
Patient 4
This 50-year-old Caucasian man had been diagnosed
with HIV five years previously. The date of infection was
not known. He had been treated with ART for four years,
initially lamivudine, zidovudine and ritonavir-boosted
lopinavir, which were subsequently changed to efavirenz,
emtricitabine and tenofovir. After treatment, his CD4 cell
count had risen from 180 to 450 cells/μL. He fell ill with
fever and headaches, plus a rash, which was later diag-
n o s e da se r y t h e m am i g r a n s .S o m ed a y sl a t e rh en o t e da
right-sided facial palsy. His CSF levels of albumin and
mononuclear cells were elevated (Table 1). Titers of Bor-
relia immunoglobulin M (IgM) antibodies in his serum
and CSF were elevated, but IgG antibodies were not.
Treatment was given with 100 mg of oral doxycycline
twice daily for 21 days. The symptoms improved within a
few days after treatment initiation. At follow-up two
months later, the patient was still experiencing a slight
sensibility disturbance from the right side of his face, but
all the other symptoms had subsided and CSF pleocytosis
and albumin concentration had normalized (Figure 1).
Borrelia IgG antibodies in his serum and CSF were now
positive.
Discussion
Only a few reports of HIV-1 and LNB co-infection have
been presented. Previously, this was considered to be due
to the non-overlapping epidemiology of the two diseases;
with LNB mainly being a rural disease, while HIV-1 is
more common in urban settings [5]. HIV-1 patients
today who are treated with ART have a life expectancy
approaching that of the general population and they sel-
dom have opportunistic infections [8], thereby enabling
them to lead active lives with outdoor activities that
increase the risk of contracting Borrelia infection. The
incidence of LNB is highest in Central Europe [9], where
the prevalence of HIV-1 infection is also substantially
higher than in Sweden, where these four patients were
diagnosed. It can therefore be expected that HIV-1 and
LNB co-infection is more common than has previously
been described.
The diagnosis of LNB rests on a combination of clinical
symptoms, CSF analyses and serology. The results are
sometimes contradictory or difficult to interpret, making
the diagnosis uncertain. In these four patients, however,
the diagnosis of LNB is considered definite. At the time of
diagnosis, all these patients had CSF mononuclear pleocy-
tosis, with cell counts higher than the levels normally
observed in HIV patients [10]. Patients 1, 2 and 3 all had
high titers of IgG antibodies to Borrelia in their CSF and
serum and a positive Borrelia antibody index, indicating
the intrathecal production of specific Borrelia antibodies.
Patient 4 seroconverted from negative to positive IgG anti-
bodies to Borrelia in his serum and CSF. Furthermore, all
the patients displayed a rapid response to anti-Borrelia
treatment. There is a well-known cross-reactivity between
the Borrelia spirochete and the Treponema spirochete and
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Figure 1 CSF mononuclear cell count before and after
treatment of Lyme neuroborreliosis with oral doxycycline. Each
line represents one patient. Mean time between CSF samplings 47
days (30-70).
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syphilis. However, screening tests for syphilis were nega-
tive in all four patients. Other bacterial, viral and fungal
CNS infections were also ruled out.
Four of the five previously published cases of HIV-1
and LNB co-infection presented with typical symptoms
of LNB, including bilateral facial palsy [5], headache [4],
meningoradiculitis [3], and facial palsy and meningora-
diculitis [2]. These four patients showed complete recov-
ery on treatment with intravenous third-generation
cephalosporins. The fifth patient presented with more
severe symptoms consistent with encephalomyelitis:
altered gait and difficulties in using her hands. Treat-
ment with intravenous third-generation cephalosporins
resulted in only partial recovery [6].
Three of the four patients described in this article pre-
sented with more severe, atypical symptoms and pathol-
ogy than are usually seen in patients with LNB, including
one with cognitive impairment, one with a pontine
infarction and one with normal-pressure hydrocephalus.
However, concomitant medical disorders such as alcohol
abuse in Patient 1 and previous Guillain-Barré in Patient
2 might have influenced the clinical course of LNB. The
atypical clinical picture might also have been caused by
the long disease duration before Borrelia diagnosis and
subsequent treatment; a couple of months for Patient 2,
and more than a year for Patient 3. An explanation for
the delayed diagnosis could be that more common HIV-
associated opportunistic infections and other diseases
were initially suspected. Apart from the concomitant
medical disorders and the long disease duration, it must,
however, also be suspected that these patients’ impaired
immunity contributed to the severity of the disease, as
none of these three patients had normal levels of CD4
cells. The exact mechanisms by which impaired immu-
nity in HIV infection might influence the course of dis-
ease in LNB remain to be clarified. Acute cerebral
infarction is a known but very rare manifestation of LNB,
with the pathological mechanism suspected to be a selec-
tive inflammatory process of small cerebral arteries.
Patient 2 matches those previously described with the
involvement of the posterior circulation and a generally
favorable outcome after treatment [11]. Normal-pressure
hydrocephalus in patients with LNB is an even rarer
manifestation, with only a few known cases. The patholo-
gical background is not understood. As with Patient 3,
previously described cases have also shown complete
improvement after antibiotic treatment, with no need for
ventricular shunting therapy [12].
The European Federation of Neurological Societies has
published guidelines on the management of LNB [13].
According to these guidelines, patients with early LNB
with CNS symptoms or patients with late (more than
six months of symptoms) LNB should be treated with
intravenous ceftriaxone. Of the four patients presented
here, three had late LNB with CNS symptoms and were
also the most immunocompromised. The good outcome
of treatment with oral doxycycline in these patients, in
combination with the CSF follow-up analyses, suggests
that oral doxycycline is an excellent alternative to intra-
venous ceftriaxone in this patient group.
One interesting observation in Patients 1, 2 and 3 was
the relatively higher HIV viral load in CSF compared
with plasma at time of diagnosis of the Borrelia infec-
tion (Table 1). This shows that concomitant meningeal
inflammation and the recruitment of lymphocytes to the
CNS in HIV infection increase the CNS viral load, prob-
ably by the Trojan horse pathway [14]. Similar findings
have been observed in patients with cryptococcal and
tuberculous meningitis [15].
Conclusions
In this case series, we present four patients with HIV-1
and LNB co-infection diagnosed in Western Sweden, an
area with a low HIV-1 prevalence and a medium incidence
of LNB. Thus, co-infection with HIV-1 and LNB is prob-
ably more common than previously thought. The three
patients that were the most immunocompromised suffered
from more severe and atypical neurological symptoms
than are usually described among patients with LNB. It is
therefore important for doctors treating HIV patients to
consider LNB if a patient presents with neurological symp-
toms. All four patients were treated with oral doxycycline
with a good outcome further proving the efficacy of this
regime.
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